Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,295 | 2,708 | 1,433 | 2,129 | 1,739 |
| Marketable Securities | N/A | N/A | N/A | N/A | 79 |
| Receivables | 9,324 | 12,298 | 13,883 | 12,358 | 17,116 |
| Inventories | 2,125 | 2,309 | 2,581 | 2,122 | 1,678 |
| TOTAL | $15,947 | $20,200 | $20,457 | $19,499 | $23,222 |
| Non-Current Assets | |||||
| PPE Net | 1,142 | 6,750 | 6,822 | 6,601 | 7,160 |
| Investments And Advances | 8,237 | 75 | 75 | 0 | 83 |
| Intangibles | 6,931 | 17,484 | 17,484 | 17,484 | 17,484 |
| Other Non-Current Assets | 3,708 | 8,686 | 8,520 | 8,249 | 7,695 |
| TOTAL | $20,019 | $32,994 | $32,900 | $32,334 | $32,421 |
| Total Assets | $35,965 | $53,194 | $53,357 | $51,833 | $55,643 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 925 | 3,418 | 3,680 | 3,422 | 2,754 |
| Accounts payable and accrued liabilities | 5,360 | 1,980 | 2,617 | 1,677 | 4,159 |
| Accrued Expenses | 470 | 640 | 582 | 556 | 469 |
| Other current liabilities | 114 | 1,509 | 1,332 | 2,197 | 3,712 |
| TOTAL | $11,065 | $9,624 | $10,046 | $9,446 | $12,449 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69 | 812 | 1,476 | 1,498 | 1,483 |
| Other Non-Current Liabilities | 1,325 | 16,666 | 16,654 | 1,173 | 17,377 |
| TOTAL | $1,402 | $18,120 | $18,857 | $4,528 | $18,944 |
| Total Liabilities | $12,466 | $27,744 | $28,903 | $13,975 | $31,393 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,290 | 1,236 | 1,017 | 1,009 | 1,009 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -11,954 | -5,779 | -5,199 | -4,663 | -4,516 |
| Other shareholders' equity | -1,083 | -3,740 | -3,665 | 9,333 | -4,124 |
| TOTAL | $23,499 | $25,451 | $24,454 | $37,858 | $24,251 |
| Total Liabilities And Equity | $35,966 | $53,194 | $53,357 | $51,833 | $55,643 |